Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease

doi:10.5409/wjcp.v14.i3.105731

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (19)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=17

Sep 9, 2025 (publication date) through Jun 16, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence Review

World J Clin Pediatr. Sep 9, 2025; 14(3): 105731
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.105731

Open in New Tab Full Size Figure Download Figure

Figure 1 Effects of glucagon-like peptide-1 analogs on target tissues. The illustrations are created using the paid version of the BioRender software. A publishing license has been obtained from Biorender (Supplementary material).

Citation: Rehman R. Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease. World J Clin Pediatr 2025; 14(3): 105731
URL: https://www.wjgnet.com/2219-2808/full/v14/i3/105731.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i3.105731